DIVA Laboratories, Ltd. (4153.TWO)

TWD 38.75

(-1.77%)

Eps Summary of DIVA Laboratories, Ltd.

  • DIVA Laboratories, Ltd.'s latest annual eps in 2023 was 1.25 TWD , up 47.06% from previous year.
  • DIVA Laboratories, Ltd.'s latest quarterly eps in 2024 Q3 was 0.26 TWD , down -50.0% from previous quarter.
  • DIVA Laboratories, Ltd. reported an annual eps of 0.85 TWD in 2022, up 129.73% from previous year.
  • DIVA Laboratories, Ltd. reported an annual eps of 0.37 TWD in 2021, up 42.31% from previous year.
  • DIVA Laboratories, Ltd. reported a quarterly eps of 0.42 TWD for 2024 Q1, up 16.67% from previous quarter.
  • DIVA Laboratories, Ltd. reported a quarterly eps of 0.52 TWD for 2024 Q2, up 23.81% from previous quarter.

Annual Eps Chart of DIVA Laboratories, Ltd. (2023 - 2019)

Historical Annual Eps of DIVA Laboratories, Ltd. (2023 - 2019)

Year Eps Eps Growth
2023 1.25 TWD 47.06%
2022 0.85 TWD 129.73%
2021 0.37 TWD 42.31%
2020 0.26 TWD -66.67%
2019 0.78 TWD 0.0%

Peer Eps Comparison of DIVA Laboratories, Ltd.

Name Eps Eps Difference
BIONET Corp. 1.55 TWD 19.355%
Genetics Generation Advancement Corp. 1.07 TWD -16.822%
Welgene Biotech Co.,Ltd. -0.11 TWD 1236.364%
Puriblood Medical Co., Ltd. -3.63 TWD 134.435%
TFBS Bioscience Inc. 0.17 TWD -635.294%